Article
Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
The Journal of antimicrobial chemotherapy - 1 Mar 2010
Jørgensen Rikke Lind, Nielsen Jesper Boye, Friis-Møller Alice, Fjeldsøe-Nielsen Hans, Schønning Kristian
Abstract excerpt
OBJECTIVES: To establish the prevalence of the AmpC beta-lactamase phenotype in clinical isolates of Escherichia coli and characterize the genetic resistance mechanisms causing the observed phenotype. METHODS: Clinical E. coli (n = 74) with reduced susceptibility to third-generation cephalosporins and resistance to cefoxitin were collected from the Department of Clinical Microbiology at Hvidovre Hospital,...
Topics
Join the communities discussing this publication.